The research on Adverse Drug Events and reports (RADAR) evaluation of the quality of reports to the FDA's MedWatch system for oncology related adverse drug reactions (ADRs): Extensive improvements are needed.

被引：0
|
作者：
Bennett, CL
Morse, RE
Carson, KR
Belknap, S
Raisch, D
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Vet Adm, Albuquerque, NM USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：535S / 535S
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid (ZA) - Associated nephrotoxicity: An analysis of adverse drug reaction (ADR) reports by the research on adverse drug events and reports (RADAR) project
    McKoy, JM
    Obadina, E
    Yarnold, PR
    Kut, V
    Raisch, DW
    Bennett, CL
    [J]. BLOOD, 2004, 104 (11) : 858A - 858A
  • [2] Melanoma associated with rituximab: A RADAR (Research on Adverse Drug events And Reports) project
    Nardone, Beatrice
    Bruins, Finola M.
    Massimino, Doriana
    Arabyat, Rasha
    Raisch, Dennis W.
    West, Dennis P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB209 - AB209
  • [3] Evaluation of Spontaneous Adverse Event Reports for Muscle Related Adverse Reactions Attributed to Daptomycin within the FDA Adverse Events Reporting System (FAERS)
    Khedr, Ola F.
    Shokr, Hala
    Mekkawy, Mohamed A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 315 - 315
  • [4] Clinical trials, case reports, and observational databases as sources of information on serious cancer-related adverse drug reactions (sADRs): Lessons learned from the Research on Adverse Drug Events and Reports (RADAR) project
    Bennett, C.
    Gleason, K.
    Djulbegovic, B.
    Raisch, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Hypomagnesemia and exposure to romidepsin: A Research on Adverse Drug events and Reports (RADAR) project.
    Lee, Dylan E.
    Serrano, Linda
    Martinez-Escala, Estela
    Kaplan, Jason B.
    Pro, Barbara
    Guitart, Joan
    Temps, William H.
    West, Dennis P.
    Belknap, Steven M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
    Katherine C. Allen
    Amanda H. Champlain
    Jonathan A. Cotliar
    Steven M. Belknap
    Dennis P. West
    Jayesh Mehta
    Steven M. Trifilio
    [J]. Drug Safety, 2015, 38 : 183 - 187
  • [7] Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
    Allen, Katherine C.
    Champlain, Amanda H.
    Cotliar, Jonathan A.
    Belknap, Steven M.
    West, Dennis P.
    Mehta, Jayesh
    Trifilio, Steven M.
    [J]. DRUG SAFETY, 2015, 38 (02) : 183 - 187
  • [8] Reporting of Serious Adverse Events During Cancer Clinical Trials to the Institutional Review Board: An Evaluation by the Research on Adverse Drug Events And Reports (RADAR) Project
    Belknap, S. M.
    Georgopoulos, C. H.
    Lagman, J.
    Weitzman, S. A.
    Qualkenbush, L.
    Yarnold, P. R.
    Edwards, B. J.
    McKoy, J. M.
    Trifilio, S. M.
    West, D. P.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12): : 1334 - 1340
  • [9] Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
    McKoy, June M.
    Fisher, Matthew J.
    Courtney, D. Mark
    Raisch, Dennis W.
    Edwards, Beatrice J.
    Scheetz, Marc H.
    Belknap, Steven M.
    Trifilio, Steven M.
    Samaras, Athena T.
    Liebling, Dustin B.
    Nardone, Beatrice
    Tulas, Katrina Marie
    West, Dennis P.
    [J]. DRUG SAFETY, 2013, 36 (05) : 335 - 347
  • [10] Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
    June M. McKoy
    Matthew J. Fisher
    D. Mark Courtney
    Dennis W. Raisch
    Beatrice J. Edwards
    Marc H. Scheetz
    Steven M. Belknap
    Steven M. Trifilio
    Athena T. Samaras
    Dustin B. Liebling
    Beatrice Nardone
    Katrina Marie Tulas
    Dennis P. West
    [J]. Drug Safety, 2013, 36 : 335 - 347
12345